Client characteristics and substance use patterns in different models of methadone maintenance therapy (MMT)

References

• Bart, G. (2012). Maintenance medication for opiate addiction: The foundation of recovery. Journal of Addictive Diseases, 31(3), 207–225. doi:10.1080/10550887.2012.694598
   PubMed Web of Science ®Google Scholar
• Bohnert, A. S., Eisenberg, A., Whiteside, L., Price, A., McCabe, S. E., & Ilgen, M. A. (2013). Prescription opioid use among addiction treatment patients: Nonmedical use for pain relief vs. other forms of nonmedical use. Addictive Behaviors, 38, 1776–1781. doi:10.1016/j.addbeh.2012.11.005
   PubMed Web of Science ®Google Scholar
• Brands, B., Blake, J., Marsh, D. C., Sproule, B., Jeyapalan, R., & Li, S. (2008). The impact of benzodiazepine use on methadone maintenance treatment outcomes. Journal of Addictive Diseases, 27, 37–48. doi:10.1080/10550880802122620
   PubMed Web of Science ®Google Scholar
• Brooner, R. K., Kidorf, M. S., King, V. L., Pierce, J., Neufeld, K., Stoller, K., & Kolodner, K. (2013). Managing psychiatric comorbidity within versus outside methadone treatment settings: A randomized and controlled evaluation. Addiction, 108, 1942–1951. doi:10.1111/add.12269
   PubMed Web of Science ®Google Scholar
• Bruneau, J., Ahamad, K., Goyer, M. E., Poulin, G., Selby, P., Fischer, B., … Wood, E. (2018). Management of opioid use disorders: A national clinical practice guideline. Canadian Medical Association Journal, 190(9), E247–E257. doi:10.1503/cmaj.170958
   PubMed Web of Science ®Google Scholar
• Christie, T. K. S., Murugesan, A., Manzer, D., O’Shaughnessey, M. V., & Webster, D. (2013). Evaluation of a low-threshold/high-tolerance methadone maintenance treatment clinic in Saint John, New Brunswick, Canada: One year retention rate and illicit drug use. Journal of Addiction, 2013(753409), 1–5. doi:10.1155/2013/753409
   Google Scholar
• Damon, W., Small., W., Anderson, S., Maher, L., Wood, E., Kerr, T., & McNeil, R. (2017). ‘Crisis’ and ‘everyday’ initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation. Drug and Alcohol Review, 36, 253–260. doi:10.1111/dar.12411
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., & Hall, W. (2012). Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet, 379, 55–70. doi:10.1016/S0140-6736(11)61138-0
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Whiteford, H. A., Ferrari, A., Baxter, A. J., Charlson, F. J., Hall, W. D., … Vos, T. (2013). Global burden of disease attributable to illicit drug use and dependence: Findings from the global burden of disease study 2010. Lancet, 382, 1564–1574. doi:10.1016/S0140-6736(13)61530-5
   PubMed Web of Science ®Google Scholar
• Eibl, J., Morin, K., Leinonen, E., & Marsh, D. C. (2017). The state of opioid agonist therapy in Canada 20 years after federal oversight. The Canadian Journal of Psychiatry, 62(7), 444–450. doi:10.1177/0706743717711167
   PubMed Web of Science ®Google Scholar
• Fischer, B., Murphy, Y., Rudzinski, K., & MacPherson, D. (2016). Illicit drug use and harms, and related interventions and policy in Canada: A narrative review of select key indicators and developments since 2000. International Journal of Drug Policy, 27, 23–35. doi:10.1016/j.drugpo.2015.08.007
   PubMed Web of Science ®Google Scholar
• Fischer, B., Nakamura, N., Rush, B., Rehm, J., & Urbanoski, K. (2010). Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004–2009. Drug and Alcohol Dependence, 109, 257–260. doi:10.1016/j.drugalcdep.2010.02.001
   PubMed Web of Science ®Google Scholar
• Fischer, B., Rehm, J., Brissette, S., Brochu, S., Bruneau, J., El-Guebaly, N., … Balinuas, D. (2005). Illicit opioid use in Canada: Comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). Journal of Urban Health: Bulletin of the New York Academy of Medicine, 82(2), 250–264. doi:10.1093/jurban/jti049
   PubMed Web of Science ®Google Scholar
• Health Canada. (2014). Canadian alcohol and drug use monitoring survey (CADUMS): Summary of results for 2012. Retrieved from https://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/summary-sommaire-eng.php
   Google Scholar
• Hser, Y., Evans, E., Grella, C., Ling, W., & Anglin, D. (2015). Long-term course of opioid addiction. Harvard Review of Psychiatry, 23(2), 76–89. doi:10.1097/HRP.0000000000000052
   PubMed Web of Science ®Google Scholar
• Jaremko, K. M., Sterling, R. C., & Van Bockstaele, E. J. (2015). Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance. Journal of Substance Abuse Treatment, 48, 117–127. doi:10.1016/j.jsat.2014.08.006
   PubMed Web of Science ®Google Scholar
• Jones, J. D., Mogali, S., & Comer, S. D. (2012). Polydrug use: A review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence, 15, 8–18. doi:10.1016/j.drugalcdep.2012.07.004
   Google Scholar
• Keyser-Marcus, L., Alvanzo, A., Rieckmann, T., Thacker, L., Sepulveda, A., Forcehimes, A., … Svikis, D. S. (2015). Trauma, gender, and mental health symptoms in individuals with substance use disorders. Journal of Interpersonal Violence, 30(1), 3–24. doi:10.1177/0886260514532523
   PubMed Web of Science ®Google Scholar
• Kourounis, G., Richards, B. D. W., Kyprianou, E., Symeonidou, E., Malliori, M., & Samartzis, L. (2016). Opioid substitution therapy: Lowering the treatment thresholds. Drug and Alcohol Dependence, 161, 1–8. doi:10.1016/j.drugalcdep.2015.12.021
   PubMed Web of Science ®Google Scholar
• Luce, J., & Strike, C. (2011). A cross-Canada scan of methadone maintenance treatment policy developments. Toronto: Canadian Executive Council on Addictions.
   Google Scholar
• Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, 2(CD002207). doi:10.1002/14651858.CD002207.pub4
   Google Scholar
• McLellan, A., Kushner, H., Metzger, D., Peter, R., Smith, I., Grissom, G., … Argeriou, M. (1992). The fifth edition of the addiction severity index: Historical critique and normative data. Journal of Substance Abuse Treatment, 9, 199–213. doi:10.1016/0740-5472(92)90062-S
   PubMed Web of Science ®Google Scholar
• Morrison, K. B., Brunelle, C., Campbell, M. A., Christie, T. K. S., & Hildebrand, J. (2017). Diversity in the needs and outcomes of low threshold/high tolerance methadone maintenance therapy clients. Canadian Journal of Addiction, 8(2), 26–33. doi:10.1097/CXA.0000000000000002
   Web of Science ®Google Scholar
• Murphy, D., Hser, Y., Huang, D., Brecht, M., & Herbeck, D. (2010). Self-report of longitudinal substance use: A comparison of the UCLA natural history interview and the addiction severity index. Journal of Drug Issues, 40(2), 495–516. doi:10.1177/002204261004000210
   PubMed Web of Science ®Google Scholar
• New Brunswick Addiction Services. (2009). Methadone maintenance treatment: Policies and procedures. Fredericton, Canada: Government of New Brunswick.
   Google Scholar
• Orpana, H., Lang, M., Baxi, J., Halverson, M., Kozloff, J., Cahill, N., … Morrison, H. (2018). Canadian trends in opioid-related mortality and disability from opioid use disorder from 1990 to 2014 through the lens of the global burden of disease study. Health Promotion and Chronic Disease Prevention in Canada Research, Policy and Practice, 38(6), 234–243. doi:10.24095/hpcdp.38.6.03
   PubMed Web of Science ®Google Scholar
• Perreault, M., Julien, D., White, N. D., Raboun, D., Lauzon, P., & Milton, D. (2015). Psychological predictors of retention in a low-threshold methadone maintenance treatment for opioid addicts: A 1-year follow-up study. Substance Use and Misuse, 50, 24–31. doi:10.3109/100826084.2014.957769
   PubMed Web of Science ®Google Scholar
• Proctor, S. L., Copeland, A. L., Kopak, A. M., Hoffman, N. G., Herschman, P. L., & Polokhina, N. (2015). Predictors of patient retention in methadone maintenance treatment. Psychology of Addictive Behaviors, 29(4), 906–917. doi:10.1037/adb0000090
   PubMed Web of Science ®Google Scholar
• Statistics Canada. (2017). Canadian alcohol tobacco and drugs: 2015 summary. Retrieved from https://www.canada.ca/en/health-canada/services/canadian-tobacco-alcohol-drugs-survey/2015-summary.html
   Google Scholar
• Stitzer, M. L., & Sigmon, S. C. (2006). The treatment of opioid use dependence. Baltimore, MD: The John Hopkins University Press.
   Google Scholar
• Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J. (2012). A review of opioid dependence treatments: Pharmacological and psychosocial interventions to treat opioid addiction. Clinical Psychology Review, 30, 155–166. doi:10.1016/j.cpr.2009.10.006
   Web of Science ®Google Scholar
• Viswanath, B., Chand, P., Benegal, V., & Murthy, P. (2012). Agonist treatment in opioid use: Advances and controversy. Asian Journal of Psychiatry, 5, 125–131. doi:10.1016/j.ajp.2012.01.004
   PubMedGoogle Scholar